CONTENTS
issue 4 // November 2017
In association with
Japan’s drug delivery devices market is estimated to reach $3.4bn by 2023
Digital health was high on the agenda at the European Society of Cardiology’s 2017 conference
FDA approval of Abbott’s continuous glucose monitor marks a breakthrough for diabetes care
With only the US market left, can Bayer’s Essure sterilisation device survive in the long term?
Artificial intelligence is making its way into the medical sector, but responses are mixed
Key considerations for international device manufacturers looking to enter emerging markets
A British company plans to break into a multi-billion dollar market with the world’s smallest surgical robot
Could smart devices powered by IoT technology solve the problem of drug adherence?
Share this article
